Cell and Gene Therapy Manufacturing Services Market Trends & Growth 2025 | Major Players - Charles River Laboratories, Thermo Fisher Scientific Inc., Lonza

"Cell and Gene Therapy Manufacturing Services Market size reached US$ 6.61 Billion in 2024 and is expected to reach US$ 23.42 Billion by 2033, growing at a CAGR of 15.2% during the forecast period 2025-2033." As per DataM intelligence research report

Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/cell-and-gene-therapy-manufacturing-services-market?sp

United States: Recent Industry Developments

✅ In September 2025, Lonza expanded its US-based cell and gene therapy manufacturing facilities, emphasizing scalable production and compliance with FDA standards. Early adoption shows improved manufacturing capacity and reduced lead times for advanced therapies.

✅ In August 2025, Catalent launched new gene therapy contract manufacturing services, integrating automated cell processing and analytics. The initiative targets efficiency, consistency, and faster commercialization. Initial deployments highlight improved process reliability and reduced production bottlenecks.

✅ In July 2025, WuXi AppTec expanded its US cell therapy production platforms, focusing on high-throughput capabilities and GMP-compliant operations. Early trials report faster manufacturing timelines and enhanced quality control.

✅ In June 2025, Thermo Fisher Scientific introduced turnkey solutions for viral vector production and cell therapy manufacturing, emphasizing regulatory compliance and scalability. Pilot programs demonstrate improved productivity and reduced operational complexity.

Japan: Recent Industry Developments

✅ In September 2025, Takeda Pharmaceutical expanded its cell and gene therapy manufacturing facilities in Japan, emphasizing GMP compliance and scalable production. Early adoption shows faster therapy availability and improved quality control.

✅ In August 2025, Chugai Pharmaceutical launched automated gene therapy manufacturing platforms for clinical and commercial applications. The initiative targets efficiency, reproducibility, and regulatory compliance. Initial deployments demonstrate faster production and higher process reliability.

✅ In July 2025, Astellas Pharma expanded its cell therapy manufacturing services, integrating high-throughput cell processing and analytics. Early trials report improved operational efficiency and product consistency.

✅ In June 2025, Mitsubishi Tanabe Pharma introduced comprehensive viral vector and cell therapy production solutions, focusing on scalability and regulatory adherence. Pilot programs show improved production output and enhanced quality assurance.

Cell and Gene Therapy Manufacturing Services Market: Drivers

The cell and gene therapy manufacturing services market is witnessing rapid growth due to increasing development and commercialization of advanced therapies for genetic disorders, cancers, and rare diseases. Rising investment in biopharmaceutical research, clinical trials, and personalized medicine is driving demand for specialized manufacturing capabilities, including cell culture, viral vector production, and gene editing platforms. Technological advancements in automated bioprocessing, scalable production, and quality control systems are enhancing efficiency, reproducibility, and regulatory compliance. Expansion of contract development and manufacturing organizations (CDMOs) is supporting the outsourcing of complex production processes. Increasing collaborations between biotech companies, research institutions, and healthcare providers are further fueling market adoption.

Integration of advanced analytics, process monitoring, and digital platforms in cell and gene therapy manufacturing is enabling higher product quality, consistency, and faster time-to-market. Collaborations between manufacturers, technology providers, and regulatory agencies are fostering innovation in scalable, cost-effective, and compliant production processes. Growing demand for personalized therapies, allogeneic products, and off-the-shelf treatments is creating additional growth opportunities. Regulatory frameworks, quality standards, and supportive government initiatives are facilitating broader adoption of outsourced manufacturing services. Overall, technological advancements, rising therapy development, and industry partnerships are driving sustained growth in the cell and gene therapy manufacturing services market.

Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/cell-and-gene-therapy-manufacturing-services-market?sp

Cell and Gene Therapy Manufacturing Services Market: Major Players

Charles River Laboratories, Thermo Fisher Scientific Inc., Lonza, Merck KGaA, Catalent, Inc, Takara Bio Inc., FUJIFILM Irvine Scientific, Oxford Biomedica plc, SGS SA, and Made Scientific, among others.

Segment Covered in the Cell and Gene Therapy Manufacturing Services Market:

➥ By Type: Cell Therapy, Gene Therapy

➥ By Indication: Oncology Diseases, Cardiovascular Diseases, Orthopedic Diseases, Ophthalmology Diseases, Central Nervous System Disorders, Infectious Diseases, Others

➥ By Application: Clinical Manufacturing, Commercial Manufacturing

➥ By End-User: Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others

Research Process:

Both primary and secondary data sources have been used in the Cell and Gene Therapy Manufacturing Services Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Most Frequently Asked Questions in the Cell and Gene Therapy Manufacturing Services Market Research Industry:

➠ Who leads the Cell and Gene Therapy Manufacturing Services industry and what's their competitive positioning regarding capacity, performance, and profitability?
➠ What growth opportunities and market challenges do Cell and Gene Therapy Manufacturing Services market vendors face?
➠ Which segments show the highest growth potential and market share distribution?
➠ What factors are driving or limiting Cell and Gene Therapy Manufacturing Services market growth?
➠ What are the dominant sales and distribution strategies in the Cell and Gene Therapy Manufacturing Services industry?

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=cell-and-gene-therapy-manufacturing-services-market

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?sp

✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.